Authorized company
BYO COLOMBIA SAS
BYO COLOMBIA SAS
Colombia INVIMA·101 registered devices·Feb 08, 2022 – Jan 03, 2031
101
Total devices
4
Risk classes
2022
Earliest
2031
Latest
Recent registrations
Latest 20 INVIMA device registrations
EUROLINE COELIAC DISEASE PROFILE (IGA)
EUROLINE COELIAC DISEASE PROFILE (IGA)
10e63bae66e9fa2d1e75f8915d3031ce
IIJan 03, 2031
EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG (IGG)
EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG (IGG)
ba42926539336442a79cf5ad3e53009b
IIJan 03, 2031
ANTI-ACETYLCHOLINE RECEPTOR ELISA (IGG)
ANTI-ACETYLCHOLINE RECEPTOR ELISA (IGG)
b6e2e1dc60bcf04af624bd4cb917cfde
IIJan 03, 2031
EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG ET CN-1A (IGG)
EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG ET CN-1A (IGG)
49e3b1150fa1fb9633b21e72231dcade
IIJan 03, 2031
EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGG)
EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGG)
0ac04d01d266887082b0aa6b700cc3b5
IIJan 03, 2031
EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGM)
EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGM)
f501f07be31ddd873becfa1c5294db87
IIJan 03, 2031
EUROLINE COELIAC DISEASE PROFILE (IGG)
EUROLINE COELIAC DISEASE PROFILE (IGG)
60df07dbf892e9c5c91f3311ffb2cbd8
IIJan 03, 2031
ANTI-GAD ELISA (IGG)
ANTI-GAD ELISA (IGG)
59c1cd236efe7c8fe5f54d30bf152544
IIJan 03, 2031
ANTI-EBNA-1 ELISA (IGG)
ANTI-EBNA-1 ELISA (IGG)
7b9f76661d921b3f0e868ec5d1021b76
Dec 15, 2030
ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGG)
ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGG)
69f69ff41f49ba5215761c2302226b0b
Dec 15, 2030
EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGG)
EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGG)
b1faecf41ecdfb2be2d2f6d97bbbaa52
Dec 15, 2030
ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGM)
ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGM)
52c7ef3c8986daaef4a7aa896d789aee
Dec 15, 2030
ASPERGILLUS ANTIGEN ELISA
ASPERGILLUS ANTIGEN ELISA
a65b3ab1076297b7980cf83cfc6977b3
Dec 15, 2030
IIFT: GRANULOCYTE (HCHO) EUROPATTERN
IIFT: GRANULOCYTE (HCHO) EUROPATTERN
5a9a29ac1644ee6f46e1b417461a5aee
IIDec 15, 2030
EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGM)
EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGM)
4047a8de2808d66f1978dd11da48294b
Dec 15, 2030
2-CAT ELISA
2-CAT ELISA
8cce521f814d23169f64a2463e97e265
IINov 27, 2030
ESTRIOL UNCONJUGATED ELISA
ESTRIOL UNCONJUGATED ELISA
0f9b7dec791dd99969121a6681978480
IINov 27, 2030
ESTRIOL TOTAL ELISA
ESTRIOL TOTAL ELISA
90eaa727ab8960bc6d7023da516e77ac
IINov 27, 2030
CORTISOL IN URINE ELISA
CORTISOL IN URINE ELISA
2c46cb51d0b7c5b0179c5ea5bb000d3e
IINov 27, 2030
5-HIAA ELISA
5-HIAA ELISA
8e57b9238fb583151948c23dc69e98d9
IINov 27, 2030
Risk class distribution
Devices by risk class
II
80
79.2% of total
III
12
11.9% of total
Unspecified
6
5.9% of total
IIa
3
3.0% of total
About this profile
Explore comprehensive authorized company profile for BYO COLOMBIA SAS through Pure Global AI's free Colombia medical device database. This company manufactures 101 medical devices registered with INVIMA across 4 risk classes. Their registration history spans from Feb 08, 2022 to Jan 03, 2031.
This page provides detailed insights including recent registrations, risk class distribution (III: 12, II: 80, Unspecified: 6, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.